DiscoverAllergy @Point of Care Podcasts
Allergy @Point of Care Podcasts
Claim Ownership

Allergy @Point of Care Podcasts

Author: @Point of Care

Subscribed: 0Played: 0
Share

Description

Our @Point of Care Allergy Podcasts have healthcare experts discussing and providing information related to diagnosis, treatment, management, and other important information.
4 Episodes
Reverse
In this podcast, our faculty discuss some of the exciting new and emerging therapies for hereditary angioedema, as well as clinical management of HAE and helping patients reach their goals. Visit www.morningcommutepodcast.com/HAE4 to view the activity and CME/CE information, download the transcript, and complete the post-test and evaluation to earn CME/CE credit.
Our faculty discuss hereditary angioedema and its burden for patients. Diagnosing HAE correctly is the first step to managing this disease. What should clinicians have on their radar to distinguish HAE from allergic reactions? Visit www.morningcommutepodcast.com/HAE3 to view the activity and CME/CE information, download the transcript, and complete the post-test and evaluation to earn CME/CE credit.
In this final podcast in our series, our faculty discuss the currently approved treatments for hereditary angioedema, the importance of an early and accurate diagnosis, as well as individualizing treatment options. Visit www.morningcommutepodcast.com/HAE2 to view the activity and CME/CE information, download the transcript, and complete the post-test and evaluation to earn CME/CE credit.
In this podcast, the first of a two-part series, our faculty discuss hereditary angioedema. How easy is it to miss this diagnosis? What do clinicians need to have on their radar to distinguish HAE from allergic reactions? Our faculty provide the roadmap needed to ensure these patients get on the right track to managing their disease. Visit www.MorningCommutePodcast.com/HAE1 to view the activity and CME/CE information, download the transcript, and complete the post-test and evaluation to earn CME/CE credit.
Comments